BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32700733)

  • 1. Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
    Shimizu K; Kawashima H; Kawai A; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Oct; 50(11):1274-1281. PubMed ID: 32700733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
    Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal doxorubicin: Effective treatment for pediatric desmoid fibromatosis.
    Ananth P; Werger A; Voss S; Rodriguez-Galindo C; Janeway KA
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27905688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review.
    Koike H; Hamada S; Sakai T; Shimizu K; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Sep; 50(9):1032-1036. PubMed ID: 32533161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
    Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis.
    Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
    Eur J Cancer; 2009 Nov; 45(17):2930-4. PubMed ID: 19767198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of progressive fibromatosis to therapy with liposomal doxorubicin.
    Wehl G; Rossler J; Otten JE; Boehm N; Uhl M; Kontny U; Niemeyer C
    Onkologie; 2004 Dec; 27(6):552-6. PubMed ID: 15591714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of cyclooxygenase 2 inhibitors for desmoid tumor management: a systematic review.
    Emori M; Matsumoto Y; Murahashi Y; Yoshida M; Nishida Y
    Nagoya J Med Sci; 2021 Nov; 83(4):673-681. PubMed ID: 34916712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoid fibromatosis: MRI features of response to systemic therapy.
    Sheth PJ; Del Moral S; Wilky BA; Trent JC; Cohen J; Rosenberg AE; Temple HT; Subhawong TK
    Skeletal Radiol; 2016 Oct; 45(10):1365-73. PubMed ID: 27502790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions.
    Eastley N; McCulloch T; Esler C; Hennig I; Fairbairn J; Gronchi A; Ashford R
    Eur J Surg Oncol; 2016 Jul; 42(7):1071-83. PubMed ID: 26965303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.
    Tsukamoto S; Takahama T; Mavrogenis AF; Tanaka Y; Tanaka Y; Errani C
    Musculoskelet Surg; 2023 Mar; 107(1):7-18. PubMed ID: 35150408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of surgical treatment for asymptomatic patients with extra-peritoneal desmoid-type fibromatosis: a systematic review and meta-analysis.
    Kito M; Ogose A; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 May; 50(5):574-580. PubMed ID: 32115631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal perforation during chemotherapeutic treatment of intra-abdominal desmoid tumor in patients with Gardner's syndrome: report of two cases.
    Li W; Zhou Y; Li Q; Tong H; Lu W
    World J Surg Oncol; 2016 Jul; 14(1):178. PubMed ID: 27377916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual finding in a desmoid-type fibromatosis of the pancreas: a case report and review of the literature.
    Torres JC; Xin C
    J Med Case Rep; 2018 May; 12(1):123. PubMed ID: 29751773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study.
    Oh CR; Jeong H; Kim W; Lee JS; Song SY; Song JS; Cho KJ; Chung HW; Lee MH; Hong JY; Lee J; Kim JE; Ahn JH
    Int J Clin Oncol; 2024 Jun; 29(6):853-861. PubMed ID: 38526622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmoid-type fibromatosis: toward a holistic management.
    Penel N; Kasper B; van Der Graaf WTA
    Curr Opin Oncol; 2021 Jul; 33(4):309-314. PubMed ID: 33973549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy in adult desmoid tumors.
    Patel SR; Evans HL; Benjamin RS
    Cancer; 1993 Dec; 72(11):3244-7. PubMed ID: 8242548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
    Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
    Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-Eluting Intra-Arterial Therapy for Pediatric Extra-Abdominal Desmoid Fibromatoses: A Promising Approach for a Perplexing Disease.
    Elnekave E; Atar E; Amar S; Bruckheimer E; Knizhnik M; Yaniv I; Dujovny T; Feinmesser M; Ash S
    J Vasc Interv Radiol; 2018 Oct; 29(10):1376-1382. PubMed ID: 30075974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis.
    Gega M; Yanagi H; Yoshikawa R; Noda M; Ikeuchi H; Tsukamoto K; Oshima T; Fujiwara Y; Gondo N; Tamura K; Utsunomiya J; Hashimoto-Tamaoki T; Yamamura T
    J Clin Oncol; 2006 Jan; 24(1):102-5. PubMed ID: 16382119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.